article thumbnail

Preserving the future of heart transplantation

Nature Reviews - Cardiology

Nature Reviews Cardiology, Published online: 04 April 2025; doi:10.1038/s41569-025-01146-x Heart transplantation remains the optimal long-term treatment for appropriate patients with advanced heart failure. However, the donor heart shortage is a limiting factor, and the risk profile of transplant candidates is worsening.

article thumbnail

Immunosuppressant adherence after heart transplantation: a review on detection, prevention, and intervention strategies in a multidisciplinary

Frontiers in Cardiovascular Medicine

Heart transplantation is an effective treatment for end-stage heart disease, and postoperative patients' medication adherence is crucial for transplantation outcomes and long-term survival.

article thumbnail

Boston Children's performs elective partial heart transplant

Becker's Hospital Review - Cardiology

Discover the groundbreaking work of Boston Children's cardiac surgeons as they perform the first elective partial heart transplant on a 4-year-old boy

article thumbnail

CareDx Launches Two Expanded Indications for AlloSure Testing Services

DAIC

The Transplant Company recently announced that AlloSureis now commercially available for pediatric heart transplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 5 As with other organ transplants, the organs are at risk of rejection.

article thumbnail

Advocate Children's establishes heart transplant program

Becker's Hospital Review - Cardiology

"Discover Advocate Children's Hospital's new pediatric heart transplant program led by top doctors and certified by UNOS, in partnership with other top hospital

article thumbnail

AI tools better at predicting heart transplant rejection than standard clinical method, finds study

Medical Xpress - Cardiology

More than 4,500 heart transplants were performed in the U.S. While the lifesaving operation improves the quality of life and longevity for most recipients, organ rejection remains a risk, with acute rejection occurring in up to 32% of recipients within the first year.

article thumbnail

The impact of pre-transplant ventricular assist device support in pediatric patients with end-stage heart failure on the outcomes of heart transplantation—“a single center experience”

Frontiers in Cardiovascular Medicine

IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to heart transplantation in children with end-stage heart failure. Patients were divided into two groups: with pre transplant ventricular assist device (VAD) support and without VAD support.